SEARCH

SEARCH BY CITATION

References

  • 1
    MacDonald, I. M., A. G. W. Hunter, P. M. MacLeod, and S. B. McMurray. 1989. Growth and development in thanatophoric dysplasia. Am. J. Med. Genet. 33:508512.
  • 2
    Nakai, K., K. Yoneda, T. Moriue, A. Munehiro, N. Fujita, J. Moriue, et al. 2010. Seborrhoeic keratoses and acanthosis nigricans in a long-term survivor of thanatophoric dysplasia. Br. J. Dermatol. 163:656658.
  • 3
    Baker, K. M., D. S. Olson, C. O. Harding, and R. M. Pauli. 1997. Long-term survival in typical thanatophoric dysplasia type 1. Am. J. Med. Genet. 70:427436.
  • 4
    Katsumata, N., T. Kuno, S. Miyazaki, S. Mikami, A. Nagashima-Miyokawa, A. Nimura, et al. 1998. G370C mutation in the FGFR3 gene in a Japanese patient with thanatophoric dysplasia. Endocr. J. 45(Suppl):S171S174.
  • 5
    Kuno, T., I. Fujita, S. Miyazaki, and N. Katsumata. 2000. Markers for bone metabolism in a long-lived case of thanatophoric dysplasia. Endocr. J. 47(Suppl):S141S144.
  • 6
    Hevner, R. F. 2005. The cerebral cortex malformation in thanatophoric dysplasia: neuropathology and pathogenesis. Acta Neuropathol. 110:208221.
  • 7
    Okajima, K., K. Asai, T. Niwa, S. Ohki, H. Sobajima, J. Tyson, et al. 2002. Clinical and biochemical findings of a patient with thanatophoric dysplasia type I: additional finding of dicarboxylic aciduria. Cleft Palate Craniofac. J. 39:246248.